Global Nanomedicine Market to Reach USD 779.2 Billion by 2033, Impelled by Growing Prevalence of Chronic Diseases

January 03, 2025 | Healthcare

The latest report by IMARC Group, titled "Nanomedicine Market Report by Nanomolecule Type (Nanoparticles, Nanoshells, Nanotubes, Nanodevices), Product (Therapeutics, Regenerative Medicine, In-Vitro Diagnostics, In-Vivo Diagnostics, Vaccines), Application (Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, and Others), and Region 2025-2033," finds that the global nanomedicine market size reached USD 294.0 Billion in 2024. Nanomedicines are specialized multi-functional drugs with programmable properties used for treating diseases and repairing tissues at a molecular level. It uses nanoparticles, nanotubes, and nanodevices, such as imaging agents, biochips, nanorobots, and polymer therapeutics, for the diagnosis, treatment, and prevention of numerous disorders, including cardiovascular, neurodegenerative, musculoskeletal, and inflammatory diseases. As a result, nanomedicine finds extensive applications for diagnostic imaging, drug delivery, vaccines, regenerative medicines, and implants.

Global Nanomedicine Market Trends:

The market is primarily driven by the growing prevalence of chronic medical ailments such as oncological, neurological, urological, infectious, ophthalmological, orthopedic, immunological, and cardiovascular diseases across the globe. In addition, various advancements in nanoscale technologies for improved diagnostic procedures represent another major growth-inducing factor. Besides this, the market is further propelled by the shifting consumer inclination toward personalized medicines. Furthermore, the increasing improvements in the healthcare infrastructure, and extensive research and development (R&D) activities conducted by key players in the field of biotechnology, are also anticipated to augment the market growth in the coming years. Looking forward, IMARC Group expects the market to reach a value of USD 779.2 Billion by 2033, exhibiting a CAGR of 10.86% during 2025-2033.

Market Summary:

  • Based on the nanomolecule type, the market has been classified into nanoparticles (metal and metal oxide nanoparticles, liposomes, polymers, and polymer-drug conjugates, hydrogel nanoparticles, dendrimers, and inorganic nanoparticles), nanoshells, nanotubes, and nanodevices.
  • On the basis of the product, the market has been segmented into therapeutics, regenerative medicine, in-vitro diagnostics, in-vivo diagnostics, and vaccines.
  • Based on the application, the market has been categorized into clinical oncology, infectious diseases, clinical cardiology, orthopedics, and others.
  • Region-wise, the market has been divided into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the market has been examined in the report, with some of the key players being Abbott Laboratories, Arrowhead Pharmaceuticals Inc., General Electric Company, Luminex Corporation, Merck & Co. Inc., Nanobiotix, Novartis AG, Pfizer Inc., Sanofi SA, and Starpharma Holdings Limited.


Report Scope:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Billion USD
Segment Coverage Nanomolecule Type, Product, Application, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Arrowhead Pharmaceuticals Inc., General Electric Company, Luminex Corporation, Merck & Co. Inc., Nanobiotix, Novartis AG, Pfizer Inc., Sanofi SA and Starpharma Holdings Limited
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Nanomedicine Market to Reach USD 779.2 Billion by 2033, Impelled by Growing Prevalence of Chronic Diseases
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials